Related Experiment Video
Updated: Jun 4, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
Female reproductive factors and primary open-angle glaucoma in the Nurses' Health Study
1Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Brigham and Women's Hospital, Harvard Medical School, 243 Charles Street, Boston, MA 02114, USA. Louis_Pasquale@meei.harvard.edu
Long-term oral contraceptive (OC) use, specifically 5 or more years, is linked to a modest increase in primary open-angle glaucoma (POAG) risk. These findings suggest estrogen may play a role in POAG development.
Area of Science:
- Ophthalmology
- Reproductive Health
- Endocrinology
Background:
- Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness worldwide.
- Reproductive factors, including oral contraceptive (OC) use, have been investigated for potential links to POAG pathogenesis.
- Estrogen's role in ocular health and its potential influence on glaucoma risk warrant further exploration.
Purpose of the Study:
- To investigate the association between age at menarche, parity, and oral contraceptive (OC) use with the risk of developing primary open-angle glaucoma (POAG).
Main Methods:
- Prospective cohort study of 79,440 women from the Nurses' Health Study (1980-2006).
- Incident POAG cases were identified, and multivariable proportional hazards models were used to calculate risks.
- Data on reproductive history and OC use were collected via biennial questionnaires.
Main Results:
- No significant association was found between age at menarche or reproductive duration and POAG risk.
- Ever using OCs was not significantly associated with POAG risk.
- However, using OCs for ≥5 years was associated with a 25% increased risk of POAG (MVRR=1.25; 95% CI, 1.02, 1.53).
- Among past OC users, a shorter time since cessation was linked to increased POAG risk.
- Parity showed no association with POAG risk.
Conclusions:
- Oral contraceptive use of 5 years or longer is associated with a modestly increased risk of primary open-angle glaucoma.
- These findings support a potential role for circulating estrogen in the development of POAG.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Nursing Assessment of the Genitourinary System I: Health History
